Jeff Geschwind, MD leverages his vast expertise as a consultant for Cage Pharma. He drives innovation in metabolic cancer research, seeking to disrupt the energy sources that tumors need to grow and spread. https://www.onclive.com/authors/jeff-geschwind-md-johns-hopkins